Curr Urol Rep (2017) 18: 80 DOI 10.1007/s11934-017-0726-3 PROSTATE CANCER (S PRASAD, SECTION EDITOR) Laurence Klotz Published online: 11 August 2017 Springer Science+Business Media, LLC 2017 Abstract Genetic tissue-based biomarkers are also likely to play a role Purpose of Review Active surveillance is now widely utilized in enhancing decision making. for the management of low-risk prostate cancer (PCa). The . . limits of surveillance for men with intermediate risk cancer Keywords Prostate cancer Active surveillance are controversial. While there is a broad consensus that men Intermediate risk with low-risk disease can be safely managed with AS, many potential candidates, including those with Gleason 3 + 4 dis- ease, PSA >10, younger men and African-Americans are often Introduction excluded. Recent Findings Outcome data for intermediate-risk patients Once considered heresy, it is now widely accepted that many managed by active surveillance demonstrate reasonable out- patients with prostate cancer can be managed conservatively, comes, but these men clearly are at higher risk for progression with periodic monitoring to identify those who should be re- to metastatic disease. The use of biomarkers and classified and offered treatment. The primary parameter for multiparametric MRI will enable a more precise and person- identifying patients at
Current Urology Reports – Springer Journals
Published: Aug 11, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera